Long-term efficacy and limitations of cyclophosphamide in myasthenia gravis. [electronic resource]
- Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia Nov 2014
- 1909-14 p. digital
Publication Type: Journal Article
1532-2653
10.1016/j.jocn.2014.03.019 doi
Adult Combined Modality Therapy Cyclophosphamide--administration & dosage Drug Evaluation Drug Substitution Drug Therapy, Combination Female Follow-Up Studies Gastrointestinal Diseases--chemically induced Hematologic Diseases--chemically induced Humans Immunosuppressive Agents--administration & dosage Infections--etiology Kidney Diseases--chemically induced Male Middle Aged Myasthenia Gravis--drug therapy Plasma Exchange Pulse Therapy, Drug Pyridostigmine Bromide--therapeutic use Remission Induction Respiration, Artificial Retrospective Studies Thymectomy Treatment Outcome Young Adult